{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:16:03Z","timestamp":1793718963802,"version":"4.6.1"},"reference-count":197,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042022dx0003"],"award-info":[{"award-number":["2042022dx0003"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["824B2050"],"award-info":[{"award-number":["824B2050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82450105"],"award-info":[{"award-number":["82450105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2022YFF1002800"],"award-info":[{"award-number":["2022YFF1002800"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2025AFB125"],"award-info":[{"award-number":["2025AFB125"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023ZD0500600"],"award-info":[{"award-number":["2023ZD0500600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M762492"],"award-info":[{"award-number":["2024M762492"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.xcrm.2025.102459","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:04:00Z","timestamp":1766131440000},"page":"102459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Emerging trends in gene and cell therapy: CRISPR in DNA editing and beyond"],"prefix":"10.1016","volume":"7","author":[{"given":"Ruijin","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiubing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-0230","authenticated-orcid":false,"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102459_bib1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf5573","article-title":"C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector","volume":"353","author":"Abudayyeh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature19802","article-title":"Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection","volume":"538","author":"East-Seletsky","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib7","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u22c5T to G\u22c5C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.aaq0180","article-title":"RNA editing with CRISPR-Cas13","volume":"358","author":"Cox","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib12","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cell.2024.01.042","article-title":"Past, present, and future of CRISPR genome editing technologies","volume":"187","author":"Pacesa","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/science.add8643","article-title":"CRISPR technology: A decade of genome editing is only the beginning","volume":"379","author":"Wang","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib16","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.molcel.2018.12.003","article-title":"A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing","volume":"73","author":"Edraki","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib17","article-title":"In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102459_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.aba8853","article-title":"Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants","volume":"368","author":"Walton","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib19","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1126\/science.aas9129","article-title":"Engineered CRISPR-Cas9 nuclease with expanded targeting space","volume":"361","author":"Nishimasu","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib20","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1016\/j.molcel.2022.09.032","article-title":"DNA topology regulates PAM-Cas9 interaction and DNA unwinding to enable near-PAMless cleavage by thermophilic Cas9","volume":"82","author":"Shi","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib21","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41580-019-0131-5","article-title":"The next generation of CRISPR-Cas technologies and applications","volume":"20","author":"Pickar-Oliver","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102459_bib22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1126\/science.aaq0179","article-title":"Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6","volume":"360","author":"Gootenberg","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2023.100080","article-title":"Cas12a-based one-pot SNP detection with high accuracy","volume":"2","author":"Zhang","year":"2023","journal-title":"Cell Insight"},{"key":"10.1016\/j.xcrm.2025.102459_bib24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aar6245","article-title":"CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity","volume":"360","author":"Chen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2023.100126","article-title":"Characterization of a thermostable Cas12a ortholog","volume":"2","author":"Wu","year":"2023","journal-title":"Cell Insight"},{"key":"10.1016\/j.xcrm.2025.102459_bib26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41551-022-00861-x","article-title":"Fast and sensitive detection of SARS-CoV-2 RNA using suboptimal protospacer adjacent motifs for Cas12a","volume":"6","author":"Lu","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2025.102459_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2025.100228","article-title":"Structure-Guided design of Cas12a variants improves detection of nucleic acids","volume":"4","author":"Tong","year":"2025","journal-title":"Cell Insight"},{"key":"10.1016\/j.xcrm.2025.102459_bib28","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1007\/s11033-023-08240-8","article-title":"Research progress on nucleic acid detection and genome editing of CRISPR\/Cas12 system","volume":"50","author":"Yang","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.xcrm.2025.102459_bib29","article-title":"CRISPR\/Cas12a-Based Biosensing: Advances in Mechanisms and Applications for Nucleic Acid Detection","volume":"15","author":"Du","year":"2025","journal-title":"Biosensors (Basel)"},{"key":"10.1016\/j.xcrm.2025.102459_bib30","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.molcel.2018.11.021","article-title":"Mechanistic Insights into the cis- and trans-Acting DNase Activities of Cas12a","volume":"73","author":"Swarts","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib31","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1038\/s41467-021-24017-8","article-title":"AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102459_bib32","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1182\/blood-2019-130256","article-title":"EDIT-301: An Experimental Autologous Cell Therapy Comprising Cas12a-RNP Modified mPB-CD34+ Cells for the Potential Treatment of SCD","volume":"134","author":"De Dreuzy","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102459_bib33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41467-018-08224-4","article-title":"Engineering of CRISPR-Cas12b for human genome editing","volume":"10","author":"Strecker","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102459_bib34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1056\/NEJMoa2503822","article-title":"Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression","volume":"393","author":"Carlsson","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib35","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tig.2021.02.008","article-title":"DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing","volume":"37","author":"Xue","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.xcrm.2025.102459_bib36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.molcel.2021.12.026","article-title":"CRISPR-based genome editing through the lens of DNA repair","volume":"82","author":"Nambiar","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s11427-024-2699-5","article-title":"Advancing CRISPR base editing technology through innovative strategies and ideas","volume":"68","author":"Fan","year":"2025","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.xcrm.2025.102459_bib38","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/cr.2017.111","article-title":"Enhanced base editing by co-expression of free uracil DNA glycosylase inhibitor","volume":"27","author":"Wang","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2025.102459_bib39","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","article-title":"Crystal structure of Cas9 in complex with guide RNA and target DNA","volume":"156","author":"Nishimasu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib40","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nbt.4199","article-title":"An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities","volume":"36","author":"Gehrke","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib41","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41556-021-00671-4","article-title":"Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations","volume":"23","author":"Wang","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102459_bib42","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41556-020-0518-8","article-title":"Increasing the efficiency and targeting range of cytidine base editors through fusion of a single-stranded DNA-binding protein domain","volume":"22","author":"Zhang","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102459_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41587-020-0609-x","article-title":"CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells","volume":"39","author":"Kurt","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib44","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41587-023-01821-9","article-title":"Adenine transversion editors enable precise, efficient A\u22c5T-to-C\u22c5G base editing in mammalian cells and embryos","volume":"42","author":"Chen","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib45","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41587-022-01595-6","article-title":"Programmable A-to-Y base editing by fusing an adenine base editor with an N-methylpurine DNA glycosylase","volume":"41","author":"Tong","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib46","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/s41589-025-01867-7","article-title":"TOPO-seq reveals DNA topology-induced off-target activity by Cas9 and base editors","volume":"21","author":"Duan","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.xcrm.2025.102459_bib47","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1016\/j.cell.2023.07.039","article-title":"Phage-assisted evolution and protein engineering yield compact, efficient prime editors","volume":"186","author":"Doman","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib48","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","article-title":"Enhanced prime editing systems by manipulating cellular determinants of editing outcomes","volume":"184","author":"Chen","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib49","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1016\/j.cell.2025.07.010","article-title":"AI-generated MLH1 small binder improves prime editing efficiency","volume":"188","author":"Park","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib50","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41587-021-01039-7","article-title":"Engineered pegRNAs improve prime editing efficiency","volume":"40","author":"Nelson","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib51","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-024-07259-6","article-title":"Improving prime editing with an endogenous small RNA-binding protein","volume":"628","author":"Yan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib52","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.cell.2023.03.034","article-title":"Prediction of efficiencies for diverse prime editing systems in multiple cell types","volume":"186","author":"Yu","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib53","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41587-024-02394-x","article-title":"Rapid generation of long, chemically modified pegRNAs for prime editing","volume":"43","author":"Lei","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib54","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.addr.2020.10.014","article-title":"Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing","volume":"168","author":"Chen","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.xcrm.2025.102459_bib55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","article-title":"Prime editing for precise and highly versatile genome manipulation","volume":"24","author":"Chen","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.xcrm.2025.102459_bib56","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41587-023-01915-4","article-title":"Genotoxic effects of base and prime editing in human hematopoietic stem cells","volume":"42","author":"Fiumara","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib57","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41580-023-00697-6","article-title":"CRISPR technologies for genome, epigenome and transcriptome editing","volume":"25","author":"Villiger","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102459_bib58","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41587-021-01133-w","article-title":"Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing","volume":"40","author":"Anzalone","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib59","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1093\/nar\/gkac506","article-title":"Bi-PE: bi-directional priming improves CRISPR\/Cas9 prime editing in mammalian cells","volume":"50","author":"Tao","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102459_bib60","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41592-022-01399-1","article-title":"Efficient targeted insertion of large DNA fragments without DNA donors","volume":"19","author":"Wang","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102459_bib61","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41587-022-01527-4","article-title":"Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases","volume":"41","author":"Yarnall","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41551-024-01227-1","article-title":"Efficient site-specific integration of large genes in mammalian cells via continuously evolved recombinases and prime editing","volume":"9","author":"Pandey","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2025.102459_bib63","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib64","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1038\/s41586-018-0380-z","article-title":"Large deletions induced by Cas9 cleavage","volume":"560","author":"Adikusuma","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41589-021-00889-1","article-title":"Increasing the efficiency and precision of prime editing with guide RNA pairs","volume":"18","author":"Zhuang","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.xcrm.2025.102459_bib66","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41587-021-01025-z","article-title":"Precise genomic deletions using paired prime editing","volume":"40","author":"Choi","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib67","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ymthe.2022.09.008","article-title":"Targeted genomic translocations and inversions generated using a paired prime editing strategy","volume":"31","author":"Kweon","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102459_bib68","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41587-021-01026-y","article-title":"Deletion and replacement of long genomic sequences using prime editing","volume":"40","author":"Jiang","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib69","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1016\/j.cell.2024.05.056","article-title":"Amplification editing enables efficient and precise duplication of DNA from short sequence to megabase and chromosomal scale","volume":"187","author":"Zhang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib70","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41592-021-01124-4","article-title":"Programmable RNA editing with compact CRISPR\u2013Cas13 systems from uncultivated microbes","volume":"18","author":"Xu","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102459_bib71","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41587-022-01419-7","article-title":"High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects","volume":"41","author":"Tong","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib72","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41593-024-01838-6","article-title":"An RNA editing strategy rescues gene duplication in a mouse model of MECP2 duplication syndrome and nonhuman primates","volume":"28","author":"Yang","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.xcrm.2025.102459_bib73","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41586-021-03886-5","article-title":"Programmable RNA targeting with the single-protein CRISPR effector Cas7-11","volume":"597","author":"\u00d6zcan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib74","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41587-022-01649-9","article-title":"Precise transcript targeting by CRISPR-Csm complexes","volume":"41","author":"Colognori","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib75","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1126\/science.aax7063","article-title":"A cytosine deaminase for programmable single-base RNA editing","volume":"365","author":"Abudayyeh","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib76","doi-asserted-by":"crossref","first-page":"2206813","DOI":"10.1002\/advs.202206813","article-title":"Develop a compact RNA base editor by fusing ADAR with engineered","volume":"10","author":"Wang","year":"2023","journal-title":"EcCas6e. Adv. Sci."},{"key":"10.1016\/j.xcrm.2025.102459_bib77","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib78","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41592-020-0966-x","article-title":"An efficient KRAB domain for CRISPRi applications in human cells","volume":"17","author":"Alerasool","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102459_bib79","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41592-018-0048-5","article-title":"An enhanced CRISPR repressor for targeted mammalian gene regulation","volume":"15","author":"Yeo","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102459_bib80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cels.2017.08.011","article-title":"Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor \u03b1-Bound Enhancers","volume":"5","author":"Carleton","year":"2017","journal-title":"Cell Syst."},{"key":"10.1016\/j.xcrm.2025.102459_bib81","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nmeth.2600","article-title":"RNA-guided gene activation by CRISPR-Cas9-based transcription factors","volume":"10","author":"Perez-Pinera","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102459_bib82","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nmeth.2598","article-title":"CRISPR RNA-guided activation of endogenous human genes","volume":"10","author":"Maeder","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102459_bib83","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature14136","article-title":"Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex","volume":"517","author":"Konermann","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib84","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2014.09.039","article-title":"A protein-tagging system for signal amplification in gene expression and fluorescence imaging","volume":"159","author":"Tanenbaum","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib85","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.1246981","article-title":"Genetic screens in human cells using the CRISPR-Cas9 system","volume":"343","author":"Wang","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib86","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib87","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41591-025-03508-x","article-title":"A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels","volume":"31","author":"Tremblay","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib88","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.7150\/thno.43465","article-title":"A review of emerging physical transfection methods for CRISPR\/Cas9-mediated gene editing","volume":"10","author":"Fajrial","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.xcrm.2025.102459_bib89","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjad018","article-title":"Efficient non-viral delivery of macromolecules in human primary hematopoietic stem cells and lymphocytes","volume":"15","author":"Zhang","year":"2023","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102459_bib90","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 Gene Editing for Sickle Cell Disease and \u03b2-Thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib91","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T cells in patients with refractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib92","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.stem.2020.05.008","article-title":"Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity","volume":"27","author":"Zhu","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib93","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1016\/j.ymthe.2024.07.015","article-title":"Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses","volume":"32","author":"Frati","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102459_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2025.100249","article-title":"cGAS, an innate dsDNA sensor with multifaceted functions","volume":"4","author":"Liu","year":"2025","journal-title":"Cell Insight"},{"key":"10.1016\/j.xcrm.2025.102459_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2021.100001","article-title":"Regulation and function of the cGAS-MITA\/STING axis in health and disease","volume":"1","author":"Zhang","year":"2022","journal-title":"Cell Insight"},{"key":"10.1016\/j.xcrm.2025.102459_bib96","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2025.102459_bib97","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","article-title":"CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib98","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib99","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwae135","article-title":"Minimizing the ratio of ionizable lipid in lipid nanoparticles for in vivo base editing","volume":"11","author":"Chen","year":"2024","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.xcrm.2025.102459_bib100","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib101","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","article-title":"Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing","volume":"20","author":"Liu","year":"2021","journal-title":"Nat. Mater."},{"key":"10.1016\/j.xcrm.2025.102459_bib102","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41587-023-01689-9","article-title":"Lipid nanoparticle-enabled gene editing in the lung via inhalation","volume":"41","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib103","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3","volume":"118","author":"Qiu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102459_bib104","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib105","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41587-020-00781-8","article-title":"Targeting herpes simplex virus with CRISPR-Cas9 cures herpetic stromal keratitis in mice","volume":"39","author":"Yin","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib106","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1126\/science.abg6155","article-title":"Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery","volume":"373","author":"Segel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib107","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41551-023-01032-2","article-title":"Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes","volume":"7","author":"Foss","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2025.102459_bib108","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1038\/s41467-019-12922-y","article-title":"Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia","volume":"10","author":"Krishnamurthy","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102459_bib109","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41467-024-45998-2","article-title":"Engineering self-deliverable ribonucleoproteins for genome editing in the brain","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102459_bib110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-023-05870-7","article-title":"Programmable protein delivery with a bacterial contractile injection system","volume":"616","author":"Kreitz","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib111","article-title":"Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains","volume":"120","author":"Wang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102459_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-025-02774-x","article-title":"Targeted delivery of diverse biomolecules with engineered bacterial nanosyringes","author":"Kreitz","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib113","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41551-023-01073-7","article-title":"Enhancement of the viability of T cells electroporated with DNA via osmotic dampening of the DNA-sensing cGAS-STING pathway","volume":"8","author":"An","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2025.102459_bib114","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.stem.2022.09.001","article-title":"Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells","volume":"29","author":"Ferrari","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.3471","article-title":"Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo","volume":"34","author":"Yin","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2022.100067","article-title":"Current advances of CRISPR-Cas technology in cell therapy","volume":"1","author":"Qiu","year":"2022","journal-title":"Cell Insight"},{"key":"10.1016\/j.xcrm.2025.102459_bib117","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xcrm.2025.102459_bib118","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/gim.2016.173","article-title":"\u03b2-Thalassemia","volume":"19","author":"Origa","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib119","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle Cell Disease","volume":"376","author":"Piel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib120","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/s41587-020-0551-y","article-title":"Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking","volume":"38","author":"Ferrari","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib121","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.omtn.2019.05.025","article-title":"In Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods","volume":"17","author":"Pattabhi","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.xcrm.2025.102459_bib122","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ymthe.2019.05.014","article-title":"Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates","volume":"27","author":"Romero","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102459_bib123","doi-asserted-by":"crossref","first-page":"7955","DOI":"10.1093\/nar\/gkz475","article-title":"Highly efficient editing of the \u03b2-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease","volume":"47","author":"Park","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102459_bib124","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","article-title":"Base editing of haematopoietic stem cells rescues sickle cell disease in mice","volume":"595","author":"Newby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41591-020-0790-y","article-title":"Therapeutic base editing of human hematopoietic stem cells","volume":"26","author":"Zeng","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib126","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.stem.2023.10.007","article-title":"Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs","volume":"30","author":"Han","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib127","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41551-023-01026-0","article-title":"Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice","volume":"7","author":"Everette","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2025.102459_bib128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41571-022-00704-3","article-title":"Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours","volume":"20","author":"Flugel","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102459_bib129","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/mt.2014.164","article-title":"Treatment of CD33-directed chimeric antigen receptor-modified T cells in one patient with relapsed and refractory acute myeloid leukemia","volume":"23","author":"Wang","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102459_bib130","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cell.2018.05.013","article-title":"Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib131","doi-asserted-by":"crossref","first-page":"11978","DOI":"10.1073\/pnas.1819992116","article-title":"Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies","volume":"116","author":"Borot","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102459_bib132","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41375-018-0277-8","article-title":"Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR\/Cas9-deletion of CD33 exon 2","volume":"33","author":"Humbert","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2025.102459_bib133","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.cell.2023.03.035","article-title":"Massively parallel base editing to map variant effects in human hematopoiesis","volume":"186","author":"Martin-Rufino","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib134","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231235","article-title":"Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy","volume":"220","author":"Marone","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib135","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41586-023-06496-5","article-title":"Epitope editing enables targeted immunotherapy of acute myeloid leukaemia","volume":"621","author":"Casirati","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib136","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.stem.2024.09.003","article-title":"Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemia","volume":"31","author":"Ji","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib137","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41586-024-07456-3","article-title":"Selective haematological cancer eradication with preserved haematopoiesis","volume":"630","author":"Garaud\u00e9","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib138","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi1145","article-title":"Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy","volume":"15","author":"Wellhausen","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib139","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"H\u00fctter","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib140","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa1817426","article-title":"CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia","volume":"381","author":"Xu","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib141","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymthe.2021.10.026","article-title":"Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing","volume":"30","author":"Knipping","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102459_bib142","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217887120","article-title":"CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice","volume":"120","author":"Dash","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102459_bib143","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cellsig.2004.04.007","article-title":"Chemokine receptor CCR5: insights into structure, function, and regulation","volume":"16","author":"Oppermann","year":"2004","journal-title":"Cell. Signal."},{"key":"10.1016\/j.xcrm.2025.102459_bib144","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151847","article-title":"Differential CXCR4 expression on hematopoietic progenitor cells versus stem cells directs homing and engraftment","volume":"7","author":"Felker","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2025.102459_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2024.100226","article-title":"Precision epitope editing: A path to advanced immunotherapies","volume":"4","author":"Ji","year":"2025","journal-title":"Cell Insight"},{"key":"10.1016\/j.xcrm.2025.102459_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2022.100076","article-title":"Structural basis of the TCR-pHLA complex provides insights into the unconventional recognition of CDR3\u03b2 in TCR cross-reactivity and alloreactivity","volume":"2","author":"San","year":"2023","journal-title":"Cell Insight"},{"key":"10.1016\/j.xcrm.2025.102459_bib147","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41591-024-03458-w","article-title":"T cell malignancies after CAR T cell therapy in the DESCAR-T registry","volume":"31","author":"Dulery","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib148","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/s41591-018-0201-9","article-title":"Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell","volume":"24","author":"Ruella","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/cells13020146","article-title":"Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?","volume":"13","author":"Lonez","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2025.102459_bib150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib151","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib152","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41586-019-1821-z","article-title":"Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy","volume":"576","author":"Wei","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2024.100146","article-title":"PD-1-mediated inhibition of T cell activation: Mechanisms and strategies for cancer combination immunotherapy","volume":"3","author":"Liu","year":"2024","journal-title":"Cell Insight"},{"key":"10.1016\/j.xcrm.2025.102459_bib154","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41586-022-05140-y","article-title":"Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL","volume":"609","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102459_bib155","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1016\/j.cell.2024.06.027","article-title":"Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib156","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1016\/j.cell.2023.08.041","article-title":"Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells","volume":"186","author":"Tsuchida","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib157","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/s41422-022-00721-y","article-title":"Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed\/refractory CD7-positive hematological malignancies: a phase I clinical study","volume":"32","author":"Hu","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2025.102459_bib158","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJMoa2313812","article-title":"Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis","volume":"390","author":"Hu","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib159","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa2300709","article-title":"Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia","volume":"389","author":"Chiesa","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib160","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1182\/blood-2015-02-629527","article-title":"A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies","volume":"126","author":"Mamonkin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102459_bib161","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41408-024-01082-y","article-title":"Anti-CD5 CAR-T cells with a tEGFR safety switch exhibit potent toxicity control","volume":"14","author":"Lin","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.xcrm.2025.102459_bib162","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41591-024-03282-2","article-title":"Allogeneic CD5-specific CAR-T therapy for relapsed\/refractory T-ALL: a phase 1 trial","volume":"31","author":"Pan","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib163","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ajt.16809","article-title":"Pig-to-baboon lung xenotransplantation: Extended survival with targeted genetic modifications and pharmacologic treatments","volume":"22","author":"Burdorf","year":"2022","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2025.102459_bib164","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.tem.2017.05.005","article-title":"A Unified Pathophysiological Construct of Diabetes and its Complications","volume":"28","author":"Schwartz","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2025.102459_bib165","article-title":"Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device","volume":"2","author":"Shapiro","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib166","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tips.2021.10.012","article-title":"CRISPR-based therapeutics: current challenges and future applications","volume":"43","author":"Modell","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.xcrm.2025.102459_bib167","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1016\/j.cell.2025.05.038","article-title":"An iPSC-derived CD19\/BCMA CAR-NK therapy in a patient with systemic sclerosis","volume":"188","author":"Wang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib168","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaci.2013.09.044","article-title":"Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience","volume":"133","author":"Shearer","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.xcrm.2025.102459_bib169","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41467-019-09614-y","article-title":"Gene correction for SCID-X1 in long-term hematopoietic stem cells","volume":"10","author":"Pavel-Dinu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102459_bib170","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1038\/s41467-020-17626-2","article-title":"Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome","volume":"11","author":"Rai","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102459_bib171","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah3480","article-title":"CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease","volume":"9","author":"De Ravin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib172","doi-asserted-by":"crossref","first-page":"115359","DOI":"10.1016\/j.addr.2024.115359","article-title":"Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: clinical applications","volume":"211","author":"Masarwy","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.xcrm.2025.102459_bib173","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib174","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa2412309","article-title":"CRISPR-Cas9 gene editing with Nexiguran Ziclumeran for ATTR cardiomyopathy","volume":"391","author":"Fontana","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib175","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1056\/NEJMoa2405734","article-title":"CRISPR-based therapy for hereditary angioedema","volume":"392","author":"Cohn","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib176","doi-asserted-by":"crossref","first-page":"A4139206","DOI":"10.1161\/circ.150.suppl_1.4139206","article-title":"Design of Heart-2: a phase 1b clinical trial of VERVE-102, an in vivo base editing medicine delivered by a GalNAc-LNP and targeting PCSK9 to durably lower LDL cholesterol","volume":"150","author":"Vafai","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2025.102459_bib177","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ehjcvp\/pvad103","article-title":"VERVE-101: a promising CRISPR-based gene editing therapy that reduces LDL-C and PCSK9 levels in HeFH patients","volume":"10","author":"Horie","year":"2024","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.xcrm.2025.102459_bib178","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","article-title":"Patient-specific in vivo gene editing to treat a rare genetic disease","volume":"392","author":"Musunuru","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib179","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib180","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/IAE.0000000000003133","article-title":"Leber congenital amaurosis due to cep290 mutations\u2014Severe vision impairment with a high unmet medical need: A Review","volume":"41","author":"Leroy","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.xcrm.2025.102459_bib181","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib182","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","article-title":"Gene editing for CEP290-associated retinal degeneration","volume":"390","author":"Pierce","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib183","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.ymthe.2023.08.021","article-title":"In vivo CRISPR gene editing in patients with herpetic stromal keratitis","volume":"31","author":"Wei","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102459_bib184","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xcrm.2025.102459_bib185","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/s41467-025-57831-5","article-title":"Activation of endogenous full-length utrophin by MyoAAV-UA as a therapeutic approach for Duchenne muscular dystrophy","volume":"16","author":"Wu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102459_bib186","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMoa2307798","article-title":"Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy","volume":"389","author":"Lek","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102459_bib187","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/d41573-024-00150-z","article-title":"In vivo CAR T cells move into clinical trials","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.102459_bib188","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41577-025-01174-1","article-title":"In vivo CAR engineering for immunotherapy","volume":"25","author":"Li","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102459_bib189","article-title":"Lipid nanoparticle-mediated mRNA delivery to CD34(+) cells in rhesus monkeys","author":"Kim","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib190","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1126\/science.adk9428","article-title":"In vivo editing of lung stem cells for durable gene correction in mice","volume":"384","author":"Sun","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib191","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.xcrm.2025.102459_bib192","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/s41563-024-02114-5","article-title":"Blood-brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system","volume":"24","author":"Wang","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.xcrm.2025.102459_bib193","doi-asserted-by":"crossref","DOI":"10.1126\/science.adt5199","article-title":"Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase","volume":"388","author":"Witte","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102459_bib194","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1016\/j.cell.2024.06.020","article-title":"All-RNA-mediated targeted gene integration in mammalian cells with rationally engineered R2 retrotransposons","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib195","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2024.11.001","article-title":"Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells","volume":"32","author":"Zeng","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2025.102459_bib196","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41551-021-00842-6","article-title":"Rapid manufacturing of non-activated potent CAR T cells","volume":"6","author":"Ghassemi","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2025.102459_bib197","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymthe.2023.11.020","article-title":"Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells","volume":"32","author":"Valeri","year":"2024","journal-title":"Mol. Ther."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125005324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125005324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:10:08Z","timestamp":1769760608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125005324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":197,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666379125005324"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102459","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging trends in gene and cell therapy: CRISPR in DNA editing and beyond","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102459"}}